These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 38454344)
1. p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme. Meng J; Qian W; Yang Z; Gong L; Xu D; Huang H; Jiang X; Pu Z; Yin Y; Zou J BMC Cancer; 2024 Mar; 24(1):317. PubMed ID: 38454344 [TBL] [Abstract][Full Text] [Related]
2. WNT signaling modulates chemoresistance to temozolomide in p53-mutant glioblastoma multiforme. Ma Z; Cai S; Xiong Q; Liu W; Xia H; Zhu Z; Huang Z; Yan X; Wang Q Apoptosis; 2022 Feb; 27(1-2):80-89. PubMed ID: 35037107 [TBL] [Abstract][Full Text] [Related]
3. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Lu C; Wei Y; Wang X; Zhang Z; Yin J; Li W; Chen L; Lyu X; Shi Z; Yan W; You Y Mol Cancer; 2020 Feb; 19(1):28. PubMed ID: 32039732 [TBL] [Abstract][Full Text] [Related]
4. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway. Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149 [TBL] [Abstract][Full Text] [Related]
5. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma. Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952 [TBL] [Abstract][Full Text] [Related]
6. Neuropilin-1 enhances temozolomide resistance in glioblastoma via the STAT1/p53/p21 axis. Huang P; Zhang L; Wang H; Dou C; Ju H; Yue P; Ren J Neuropathology; 2024 Aug; 44(4):319-330. PubMed ID: 38448392 [TBL] [Abstract][Full Text] [Related]
7. TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma. Yu J; Gao G; Wei X; Wang Y BMC Cancer; 2022 Jul; 22(1):786. PubMed ID: 35850753 [TBL] [Abstract][Full Text] [Related]
8. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2. Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway. Lan Y; Lou J; Hu J; Yu Z; Lyu W; Zhang B Cancer Biol Med; 2020 Feb; 17(1):112-131. PubMed ID: 32296580 [No Abstract] [Full Text] [Related]
10. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma. Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606 [TBL] [Abstract][Full Text] [Related]
11. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression. Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000 [TBL] [Abstract][Full Text] [Related]
12. The CXCL12/CXCR4 axis confers temozolomide resistance to human glioblastoma cells via up-regulation of FOXM1. Wang S; Chen C; Li J; Xu X; Chen W; Li F J Neurol Sci; 2020 Jul; 414():116837. PubMed ID: 32334273 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A-dependent manner in glioblastoma multiforme cells. Li XD; Wang MJ; Zheng JL; Wu YH; Wang X; Jiang XB Cancer Sci; 2021 Nov; 112(11):4543-4552. PubMed ID: 34390075 [TBL] [Abstract][Full Text] [Related]
14. A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme. Kim SS; Rait A; Kim E; Pirollo KF; Chang EH Nanomedicine; 2015 Feb; 11(2):301-11. PubMed ID: 25240597 [TBL] [Abstract][Full Text] [Related]
15. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme. Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406 [TBL] [Abstract][Full Text] [Related]
16. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation. Su IC; Su YK; Setiawan SA; Yadav VK; Fong IH; Yeh CT; Lin CM; Liu HW Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175412 [TBL] [Abstract][Full Text] [Related]
17. Lnc-TALC promotes O Wu P; Cai J; Chen Q; Han B; Meng X; Li Y; Li Z; Wang R; Lin L; Duan C; Kang C; Jiang C Nat Commun; 2019 May; 10(1):2045. PubMed ID: 31053733 [TBL] [Abstract][Full Text] [Related]
18. SNAP reverses temozolomide resistance in human glioblastoma multiforme cells through down-regulation of MGMT. Tsai CK; Huang LC; Wu YP; Kan IY; Hueng DY FASEB J; 2019 Dec; 33(12):14171-14184. PubMed ID: 31725331 [TBL] [Abstract][Full Text] [Related]
19. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition. Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243 [TBL] [Abstract][Full Text] [Related]
20. Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism. Lee CAA; Banerjee P; Wilson BJ; Wu S; Guo Q; Berg G; Karpova S; Mishra A; Lian JW; Tran J; Emmerich M; Murphy GF; Frank MH; Frank NY J Biol Chem; 2020 May; 295(22):7774-7788. PubMed ID: 32317280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]